Literature DB >> 29305413

The prohibitin-binding compound fluorizoline induces apoptosis in chronic lymphocytic leukemia cells ex vivo but fails to prevent leukemia development in a murine model.

Marina Wierz1, Sandrine Pierson1, Nora Chouha2, Laurent Désaubry2, Jean-Hugues François3, Guy Berchem1,3, Jerome Paggetti4, Etienne Moussay4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29305413      PMCID： PMC5865436          DOI： 10.3324/haematol.2017.175349

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  7 in total

Review 1.  Chronic lymphocytic leukaemia.

Authors:  Thomas J Kipps; Freda K Stevenson; Catherine J Wu; Carlo M Croce; Graham Packham; William G Wierda; Susan O'Brien; John Gribben; Kanti Rai
Journal:  Nat Rev Dis Primers       Date:  2017-01-19       Impact factor: 52.329

Review 2.  Microenvironment interactions and B-cell receptor signaling in Chronic Lymphocytic Leukemia: Implications for disease pathogenesis and treatment.

Authors:  Elisa Ten Hacken; Jan A Burger
Journal:  Biochim Biophys Acta       Date:  2015-07-17

3.  A trifluorinated thiazoline scaffold leading to pro-apoptotic agents targeting prohibitins.

Authors:  Alba Pérez-Perarnau; Sara Preciado; Claudia Mariela Palmeri; Cristina Moncunill-Massaguer; Daniel Iglesias-Serret; Diana M González-Gironès; Miriam Miguel; Satoki Karasawa; Satoshi Sakamoto; Ana M Cosialls; Camila Rubio-Patiño; José Saura-Esteller; Rosario Ramón; Laia Caja; Isabel Fabregat; Gabriel Pons; Hiroshi Handa; Fernando Albericio; Joan Gil; Rodolfo Lavilla
Journal:  Angew Chem Int Ed Engl       Date:  2014-09-05       Impact factor: 15.336

4.  The novel plant-derived agent silvestrol has B-cell selective activity in chronic lymphocytic leukemia and acute lymphoblastic leukemia in vitro and in vivo.

Authors:  David M Lucas; Ryan B Edwards; Gerard Lozanski; Derek A West; Jungook D Shin; Melissa A Vargo; Melanie E Davis; Darlene M Rozewski; Amy J Johnson; Bao-Ning Su; Virginia M Goettl; Nyla A Heerema; Thomas S Lin; Amy Lehman; Xiaoli Zhang; David Jarjoura; David J Newman; John C Byrd; A Douglas Kinghorn; Michael R Grever
Journal:  Blood       Date:  2009-02-03       Impact factor: 22.113

5.  The prohibitin-binding compound fluorizoline induces apoptosis in chronic lymphocytic leukemia cells through the upregulation of NOXA and synergizes with ibrutinib, 5-aminoimidazole-4-carboxamide riboside or venetoclax.

Authors:  Ana M Cosialls; Helena Pomares; Daniel Iglesias-Serret; José Saura-Esteller; Sonia Núñez-Vázquez; Diana M González-Gironès; Esmeralda de la Banda; Sara Preciado; Fernando Albericio; Rodolfo Lavilla; Gabriel Pons; Eva M González-Barca; Joan Gil
Journal:  Haematologica       Date:  2017-06-15       Impact factor: 9.941

6.  A novel prohibitin-binding compound induces the mitochondrial apoptotic pathway through NOXA and BIM upregulation.

Authors:  Cristina Moncunill-Massaguer; José Saura-Esteller; Alba Pérez-Perarnau; Claudia Mariela Palmeri; Sonia Núñez-Vázquez; Ana M Cosialls; Diana M González-Gironès; Helena Pomares; Anne Korwitz; Sara Preciado; Fernando Albericio; Rodolfo Lavilla; Gabriel Pons; Thomas Langer; Daniel Iglesias-Serret; Joan Gil
Journal:  Oncotarget       Date:  2015-12-08

7.  Targeting prohibitins induces apoptosis in acute myeloid leukemia cells.

Authors:  Helena Pomares; Claudia M Palmeri; Daniel Iglesias-Serret; Cristina Moncunill-Massaguer; José Saura-Esteller; Sonia Núñez-Vázquez; Enric Gamundi; Montserrat Arnan; Sara Preciado; Fernando Albericio; Rodolfo Lavilla; Gabriel Pons; Eva M González-Barca; Ana M Cosialls; Joan Gil
Journal:  Oncotarget       Date:  2016-10-04
  7 in total
  3 in total

Review 1.  Prohibitin ligands: a growing armamentarium to tackle cancers, osteoporosis, inflammatory, cardiac and neurological diseases.

Authors:  Dong Wang; Redouane Tabti; Sabria Elderwish; Hussein Abou-Hamdan; Amel Djehal; Peng Yu; Hajime Yurugi; Krishnaraj Rajalingam; Canan G Nebigil; Laurent Désaubry
Journal:  Cell Mol Life Sci       Date:  2020-02-15       Impact factor: 9.261

2.  The prohibitin-binding compound fluorizoline affects multiple components of the translational machinery and inhibits protein synthesis.

Authors:  Xin Jin; Jianling Xie; Michael Zabolocki; Xuemin Wang; Tao Jiang; Dong Wang; Laurent Désaubry; Cedric Bardy; Christopher G Proud
Journal:  J Biol Chem       Date:  2020-05-19       Impact factor: 5.157

Review 3.  SFPH proteins as therapeutic targets for a myriad of diseases.

Authors:  Dong Wang; Redouane Tabti; Sabria Elderwish; Amel Djehal; Nora Chouha; Franck Pinot; Peng Yu; Canan G Nebigil; Laurent Désaubry
Journal:  Bioorg Med Chem Lett       Date:  2020-10-06       Impact factor: 2.823
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.